These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2200619)
41. Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM. Yoshioka N; Kuzuya T; Matsuda A; Iwamoto Y Diabetes; 1989 Feb; 38(2):262-6. PubMed ID: 2644145 [TBL] [Abstract][Full Text] [Related]
42. Insulin, C-peptide, and proinsulin in nondiabetics and insulin-treated diabetics. Characterization of the proinsulin in insulin-treated diabetics. Heding LG Diabetes; 1978; 27 Suppl 1():178-83. PubMed ID: 631439 [No Abstract] [Full Text] [Related]
43. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. Røder ME; Porte D; Schwartz RS; Kahn SE J Clin Endocrinol Metab; 1998 Feb; 83(2):604-8. PubMed ID: 9467581 [TBL] [Abstract][Full Text] [Related]
44. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling. Herlihy OM; Barrow BA; Grant PJ; Levy JC Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743 [TBL] [Abstract][Full Text] [Related]
45. Do high proinsulin and C-peptide levels play a role in autonomic nervous dysfunction?: Power spectral analysis in patients with non-insulin-dependent diabetes and nondiabetic subjects. Töyry JP; Niskanen LK; Mäntysaari MJ; Länsimies EA; Haffner SM; Miettinen HJ; Uusitupa MI Circulation; 1997 Aug; 96(4):1185-91. PubMed ID: 9286948 [TBL] [Abstract][Full Text] [Related]
46. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis. Hamdi I; Green M; Shneerson JM; Palmer CR; Hales CN Clin Endocrinol (Oxf); 1993 Jul; 39(1):21-6. PubMed ID: 8348704 [TBL] [Abstract][Full Text] [Related]
47. Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Golay A; Swislocki AL; Chen YD; Reaven GM Metabolism; 1987 Jul; 36(7):692-6. PubMed ID: 3298937 [TBL] [Abstract][Full Text] [Related]
48. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM). Uddin F; Miah AK Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864 [TBL] [Abstract][Full Text] [Related]
49. Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study. Zethelius B; Byberg L; Hales CN; Lithell H; Berne C Diabetologia; 2003 Jan; 46(1):20-6. PubMed ID: 12637978 [TBL] [Abstract][Full Text] [Related]
50. Dynamic changes in plasma proinsulin/insulin ratio during insulin secretion influence correlation between radioimmunoassay (RIA) and IMX measurements of insulin. Stickle DF; Reynolds MA; Morris MD; Quon MJ Clin Chim Acta; 1999 Jun; 284(1):1-13. PubMed ID: 10437638 [TBL] [Abstract][Full Text] [Related]
52. Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus. Prigeon RL; Jacobson RK; Porte D; Kahn SE J Clin Endocrinol Metab; 1996 Sep; 81(9):3295-8. PubMed ID: 8784086 [TBL] [Abstract][Full Text] [Related]
53. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: the Insulin Resistance Atherosclerosis Study. Mykkänen L; Zaccaro DJ; Hales CN; Festa A; Haffner SM Diabetologia; 1999 Sep; 42(9):1060-6. PubMed ID: 10447516 [TBL] [Abstract][Full Text] [Related]
54. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics. Miyazaki K; Funakoshi A; Ibayashi H Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028 [TBL] [Abstract][Full Text] [Related]
55. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes. Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540 [TBL] [Abstract][Full Text] [Related]
56. Age-related changes of proinsulin processing in diabetic and non-diabetic Japanese individuals. Yoshino H; Kawakami K; Yoshino G; Hirose T Geriatr Gerontol Int; 2018 Jul; 18(7):1046-1050. PubMed ID: 29665183 [TBL] [Abstract][Full Text] [Related]
57. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. Jehle PM; Jehle DR; Mohan S; Böhm BO J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371 [TBL] [Abstract][Full Text] [Related]
58. Characterization and use in immunoradiometric assay of monoclonal antibodies directed against human proinsulin. Gray IP; Siddle K; Frank BH; Hales CN Diabetes; 1987 Jun; 36(6):684-8. PubMed ID: 2436963 [TBL] [Abstract][Full Text] [Related]
59. [Insulin and proinsulin content in the blood plasma in diabetes mellitus, determined by means of the gel filtration method]. Baranov VG; Khudobina GV; Orkodashvili LSh Probl Endokrinol (Mosk); 1979; 25(4):3-6. PubMed ID: 471970 [TBL] [Abstract][Full Text] [Related]
60. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Wegner M; Winiarska H; Bobkiewicz-Kozłowska T; Dworacka M Cytokine; 2008 Jun; 42(3):312-6. PubMed ID: 18397831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]